By contrast, the ANSWER trial (investigating albumin for the treatment of ascites in patients with hepatic cirrhosis) showed weekly albumin infusions to outpatients with ascites reduced the incidence of infection and improved survival.26 Here, ALB is linked to Cirrhosis.